Skip to main content
logo
Waverley Pharma Inc. (TSXV:WAVE)
Canada flag Canada · Delayed Price · Currency is CAD
0.0150
0.00 (0.00%)
Aug 19, 2026, 12:39 PM EST

Waverley Pharma Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.251.350.480.411.251.75
Revenue Growth
43.69%183.90%15.36%-66.95%-28.87%27.47%
Gross Profit
0.460.510.210.080.280.22
Operating Income
-0.45-0.35-0.86-1.28-0.94-0.79
Net Income
-0.63-0.5-0.95-2.22-0.66-0.8
Earnings Per Share
-0.01-0.01-0.02-0.04-0.01-0.01
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.070.040.240.050.130.16
Total Debt
3.543.443.071.60.70.26
Net Cash (Debt)
-3.47-3.4-2.83-1.55-0.57-0.1
Net Cash Growth
------
Net Cash Per Share
-0.06-0.06-0.05-0.03-0.01-0.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-0.51-0.61-0.41-1.02-0.24-0.8
Free Cash Flow
-0.51-0.61-0.41-1.02-0.24-0.8
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
37.34%38.06%45.03%19.36%22.76%12.70%
Operating Margin
-36.34%-25.89%-181.32%-311.30%-75.08%-44.89%
Pretax Margin
-50.34%-36.87%-199.23%-539.70%-53.26%-45.44%
Profit Margin
-50.47%-36.99%-199.23%-539.70%-53.26%-45.44%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.650.801.143.281.302.47